The case for indicator condition-guided HIV screening

HIV Medicine

Volumn 14, Issue 7, 2013, Pages 445-448

  Lazarus, Jv ^a   Hoekstra, M ^b   Raben, D ^a   Delpech, V ^c   Coenen, T ^d   Lundgren, Jd ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Independent Consultant   (Denmark)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d Health Action International Europe   (Netherlands)

Author keywords

AIDS; Europe; Health care delivery; HIV testing; Indicator conditions

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; HEALTH; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOSUPPRESSIVE TREATMENT; MONONUCLEOSIS; MORBIDITY; MORTALITY; NONHUMAN; PATIENT COUNSELING; PREGNANCY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TUBERCULOSIS; VERTICAL TRANSMISSION;

AIDS; EUROPE; HEALTH CARE DELIVERY; HIV TESTING; INDICATOR CONDITIONS;

EARLY DIAGNOSIS; EUROPE; HEALTH STATUS INDICATORS; HIV; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PRENATAL DIAGNOSIS; PREVALENCE; WORLD HEALTH ORGANIZATION;

EID: 84879838200     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12022     Document Type: Article

References (15)

1. Bygbjerg IC. AIDS in a Danish surgeon (Zaire, 1976). Lancet 1983; 321: 925.
2. Antinori A, Coenen T, Costagiola Detal. Late presentation of HIV infection: a consensus definition. HIV Med 2011; 12: 61-64.
3. European Centre for Disease Prevention and Control. HIV/AIDS Surveillance in Europe 2010. Stockholm, ECDC, 2011.
4. WHO, UNAIDS, GIZ, MSM GfF, UNDP. Prevention and Treatment of HIV and Other Sexually Transmitted Infections among Men Who Have Sex with Men and Transgender People: Recommendations for a Public Health Approach. Geneva, World Health Organization, 2011. Available at http://whqlibdoc.who.int/publications/2011/9789241501750_eng.pdf (accessed 28 June 2012).
5. Branson BM, Handsfield HH, Lampe MAetal. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55 (RR-14): 1-17. Available at http://cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm (accessed 25 April 2012).
6. WHO, UNAIDS. Guidance on Provider-initiated HIV Testing and Counselling in Health Facilities. Geneva, World Health Organization, 2007. Available at http://whqlibdoc.who.int/publications/2007/9789241595568_eng.pdf (accessed 28 June 2012).
7. HIV in Europe Initiative. Proceedings of the 2012 Copenhagen Conference. Available at www.hiveurope.eu/Copenhagen2012Conference/tabid/115/Default.aspx (accessed 28 June 2012).
8. HIV in Europe Initiative. HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings. Copenhagen, Copenhagen University, 2012.
9. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269: 729-730.
10. Paltiel AD, Weinstein MC, Kimmel ADetal. Expanded screening for HIV in the United States: an analysis of cost-effectiveness. N Engl J Med 2005; 352: 586-595.
11. Sanders GD, Bayoumi AM, Sundaram Vetal. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005; 352: 570-585.
12. Sullivan A, Raben D, Reekie Jetal. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV Indicator Diseases across Europe Study). PLoS ONE 2013; 8: e52845.
13. Egger M, May M, Chêne Getal.; ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119-129.
14. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20: 1447-1450.
15. Fleishman JA, Yehia BR, Moore RD, Gebo KA, HIV Research Network. The economic burden of late entry into medical care for patients with HIV infection. Med Care 2010; 48: 1071-1079.